Skip to content
Clinical Trials for Alzheimer's Disease

Seattle, Washington

Alzheimer's disease clinical trials in Seattle, WA

8 Alzheimer's disease studies are recruiting participants at sites in Seattle as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Seattle at a glance

  • 8 studies are recruiting at a site in Seattle.
  • By phase: Phase 2 (1), Phase 2/3 (2), Phase 3 (1), No phase (1), Observational (3). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (7), industry (1).
  • Most recent update to one of these records: October 26, 2026.

Studies recruiting in Seattle

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Alzheimer's Tau Platform: Master Protocol

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Paul S. Aisen
    Study site
    Harborview Medical Center, University of Washington
    Registry record
    NCT06957418 · updated
  2. Dominantly Inherited Alzheimer Network (DIAN)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    University of Washington
    Registry record
    NCT00869817 · updated
  3. Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Fred Hutchinson Cancer Center
    Study site
    Fred Hutchinson Cancer Center
    Registry record
    NCT06922188 · updated
  4. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study site
    University of Washington Medical Center
    Registry record
    NCT06563895 · updated
  5. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    University of Washington
    Registry record
    NCT05552157 · updated
  6. A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    University of Washington
    Registry record
    NCT06647498 · updated
  7. Late Onset Alzheimer's Disease

    • Observational
    • Ages 55 and older
    • All sexes
    Sponsor
    Columbia University
    Study site
    University of Washington
    Registry record
    NCT05010603 · updated
  8. A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

    • No phase
    • Ages 60 and older
    • All sexes
    Sponsor
    University of Washington
    Study site
    University of Washington
    Registry record
    NCT06411561 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Seattle, WA on ClinicalTrials.gov.

Ask about studies near Seattle

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call